588 reports of this reaction
4.7% of all IVERMECTIN reports
#3 most reported adverse reaction
ASTHENIA is the #3 most commonly reported adverse reaction for IVERMECTIN, manufactured by Merck Sharp & Dohme LLC. There are 588 FDA adverse event reports linking IVERMECTIN to ASTHENIA. This represents approximately 4.7% of all 12,395 adverse event reports for this drug.
Patients taking IVERMECTIN who experience asthenia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASTHENIA is moderately reported among IVERMECTIN users, representing a notable but not dominant share of adverse events.
In addition to asthenia, the following adverse reactions have been reported for IVERMECTIN:
The following drugs have also been linked to asthenia in FDA adverse event reports:
ASTHENIA has been reported as an adverse event in 588 FDA reports for IVERMECTIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASTHENIA accounts for approximately 4.7% of all adverse event reports for IVERMECTIN, making it one of the most commonly reported side effect.
If you experience asthenia while taking IVERMECTIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.